Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

292 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Distal vs Conventional Radial Access for Coronary Angiography and/or Intervention: A Meta-Analysis of Randomized Trials.
Ferrante G, Condello F, Rao SV, Maurina M, Jolly S, Stefanini GG, Reimers B, Condorelli G, Lefèvre T, Pancholy SB, Bertrand O, Valgimigli M. Ferrante G, et al. Among authors: stefanini gg. JACC Cardiovasc Interv. 2022 Nov 28;15(22):2297-2311. doi: 10.1016/j.jcin.2022.09.006. JACC Cardiovasc Interv. 2022. PMID: 36423974 Free article.
Long-term comparison of everolimus- and sirolimus-eluting stents in patients with acute coronary syndromes.
Kalesan B, Stefanini GG, Räber L, Schmutz M, Baumgartner S, Hitz S, Baldinger SH, Pilgrim T, Moschovitis A, Wenaweser P, Büllesfeld L, Khattab AA, Meier B, Jüni P, Windecker S. Kalesan B, et al. Among authors: stefanini gg. JACC Cardiovasc Interv. 2012 Feb;5(2):145-54. doi: 10.1016/j.jcin.2011.11.005. JACC Cardiovasc Interv. 2012. PMID: 22361598 Free article.
Biodegradable polymer drug-eluting stents reduce the risk of stent thrombosis at 4 years in patients undergoing percutaneous coronary intervention: a pooled analysis of individual patient data from the ISAR-TEST 3, ISAR-TEST 4, and LEADERS randomized trials.
Stefanini GG, Byrne RA, Serruys PW, de Waha A, Meier B, Massberg S, Jüni P, Schömig A, Windecker S, Kastrati A. Stefanini GG, et al. Eur Heart J. 2012 May;33(10):1214-22. doi: 10.1093/eurheartj/ehs086. Epub 2012 Mar 24. Eur Heart J. 2012. PMID: 22447805 Free article.
Safety and efficacy of drug-eluting stents in women: a patient-level pooled analysis of randomised trials.
Stefanini GG, Baber U, Windecker S, Morice MC, Sartori S, Leon MB, Stone GW, Serruys PW, Wijns W, Weisz G, Camenzind E, Steg PG, Smits PC, Kandzari D, Von Birgelen C, Galatius S, Jeger RV, Kimura T, Mikhail GW, Itchhaporia D, Mehta L, Ortega R, Kim HS, Valgimigli M, Kastrati A, Chieffo A, Mehran R. Stefanini GG, et al. Lancet. 2013 Dec 7;382(9908):1879-88. doi: 10.1016/S0140-6736(13)61782-1. Epub 2013 Sep 2. Lancet. 2013. PMID: 24007976
Predictors of adverse events among patients undergoing primary percutaneous coronary intervention: insights from a pooled analysis of the COMFORTABLE AMI and EXAMINATION trials.
Taniwaki M, Stefanini GG, Räber L, Brugaletta S, Cequier A, Heg D, Iñiguez A, Kelbæk H, Serra A, Ostoijic M, Hernandez-Antolin R, Baumbach A, Blöchlinger S, Jüni P, Mainar V, Sabate M, Windecker S. Taniwaki M, et al. Among authors: stefanini gg. EuroIntervention. 2015 Aug;11(4):391-8. doi: 10.4244/EIJY14M07_12. EuroIntervention. 2015. PMID: 25042419 Free article.
Clinical outcomes and revascularization strategies in patients with low-flow, low-gradient severe aortic valve stenosis according to the assigned treatment modality.
O'Sullivan CJ, Englberger L, Hosek N, Heg D, Cao D, Stefanini GG, Stortecky S, Gloekler S, Spitzer E, Tüller D, Huber C, Pilgrim T, Praz F, Buellesfeld L, Khattab AA, Carrel T, Meier B, Windecker S, Wenaweser P. O'Sullivan CJ, et al. Among authors: stefanini gg. JACC Cardiovasc Interv. 2015 Apr 27;8(5):704-17. doi: 10.1016/j.jcin.2014.11.020. JACC Cardiovasc Interv. 2015. PMID: 25946444 Free article.
292 results